Researchers at the Technion—Israel Institute of Technology have developed an innovative treatment for breast cancer, based on analgesic nanoparticles that target the nervous system. The study, published in Science Advances, ...
Oct 18, 2021
0
98
A group of researchers has created nanomachines that detect MMPs (matrix metalloproteinases), a principal enzyme for cancer cells to invade normal tissue, and deliver anticancer drugs according to an announcement in the journal ...
Oct 12, 2021
0
2
A non-invasive, patient-friendly imaging technique can help physicians make treatment decisions for breast cancer patients when diagnostic dilemmas arise. The 18F-FES PET scan—approved by the U.S. Food and Drug Administration ...
Sep 29, 2021
0
2
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical ...
Aug 16, 2021
0
18
A new approach to treating breast cancer kills 95-100% of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called ...
Jul 21, 2021
0
2289
A genetic map of an aggressive childhood brain tumour called medulloblastoma has helped researchers identify a new generation anti-cancer drug that can be repurposed as an effective treatment for the disease.
Jul 7, 2021
0
6
Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown.
Jun 21, 2021
0
5
Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumors have faulty copies of the BRCA cancer genes.
Jun 17, 2021
0
24
Breast cancer is the leading cause of cancer death in women around the world, responsible for 1,700 deaths every day. Although the vast majority of breast cancers are treatable, the most aggressive subtype—triple negative ...
Jun 7, 2021
0
14
Cancer drugs capable of weakening the body's immune defenses are no more likely to increase the risk of COVID-19 infection or death than breast cancer therapies that do not undermine the immune system, a new study shows. ...
May 20, 2021
0
6
